Clinical Trial: Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Treatment of Cognitive Deficits After Traumatic Brain Injury
Study Type: INTERVENTIONAL
Official Title: Treatment of Post-traumatic Cognitive Dysfunction With Memantine Hydrochloride, an N-methyl-D-aspartate (NMDA)-Type Receptor Blocker: a Clinical Trial
Brief Summary:
Posttraumatic consequences are common causes of disability and long-term morbidity.They include cognitive dysfunction, seizures, headache, dizziness, fatigue, sensory deficits, neurodegeneration and psychiatric disorders (e.g.posttraumatic stress disorder, depression, anxiety, etc).Diffuse axonal injury and disruption of normal neuronal function are the most common and important pathologic features of traumatic primary closed head injury.depression, anxiety, etc).Excitotoxicity and apoptosis caused by activation…
Read more